stem cell treatment
Scope
Date
~
-
Batteries
GM asks LG Energy to share huge portion of US EV tax benefits
General Motor Co., the leading US automaker, has asked LG Energy Solution Ltd., the world’s second-largest electric vehicle battery manufactur...
Nov 30, 2023 (Gmt+09:00)
-
Batteries
Lotte Chem develops tech to improve EV battery durability
Lotte Chemical Corp. said on Tuesday it has developed a technology to improve the durability of electric vehicle cell materials by enhancing the sta...
Nov 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Batteries
Trafigura to invest in S.Korea’s EV cell materials maker
Trafigura, a major global commodity trader, is set to invest in a South Korean electric vehicle battery raw materials manufacturer to take advantage...
Nov 17, 2023 (Gmt+09:00)
-
Batteries
SK On, BASF tie up for EV battery materials business
SK On Co., the world’s fifth-largest electric vehicle battery maker, and BASF SE, a major global cell materials producer, joined forces for th...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Electric vehicles
Polestar 4 EV to be built at Renault’s Korean plant from 2025
Swedish electric vehicle maker Polestar will build its upcoming Polestar 4 SUV coupe at Renault Group’s manufacturing plant in South Korea fro...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
-
Electric vehicles
SK On signs deal to supply NCM battery cells to Sweden’s Polestar 5 EV
SK On Co., the battery-making affiliate of South Korea’s SK Group, has signed a deal to supply nickel-cobalt-manganese (NCM) battery cell modu...
Nov 06, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests in AI startups Allganize, Imprimed
SK Telecom Co. has invested a combined 9.4 billion won ($7.2 million) in artificial intelligence startups Allganize Inc. and Imprimed Inc., the top ...
Nov 06, 2023 (Gmt+09:00)
-
Batteries
SK Ecoplant to supply fuel cells to Irish data centers
SK Ecoplant Co., a South Korean construction engineering and waste management firm, plans to provide solid oxide fuel cells (SOFC) to Irish power ge...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...
Nov 03, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Hydrogen economy
Hanwha Aerospace, KATECH to collaborate on hydrogen fuel cell
South Korea's Hanwha Aerospace Co. announced on Monday it signed a memorandum of understanding (MOU) with the Korea Automotive Technology Institute ...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho...
Oct 16, 2023 (Gmt+09:00)
-
Energy
HD KSOE to invest $48 mn in European fuel cell company
HD Korea Shipbuilding & Offshore Engineering (KSOE) announced on Wednesday that it plans to invest 45 million euros ($47.7 million) in the Europ...
Oct 11, 2023 (Gmt+09:00)
-
Hydrogen economy
Hyundai, Iveco solidify partnership with E-WAY H2 hydrogen fuel cell bus
South Korea’s top automaker Hyundai Motor Co. and Italian truck maker Iveco Group N.V. have consolidated their business partnership through th...
Oct 09, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Food & Beverage
Pulmuone, BlueNalu team up for cell-cultured seafood
South Korean food company Pulmuone revealed plans on Thursday to boost its strategic partnership with US-based seafood startup BlueNalu, focusing on...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Construction
Hyundai Engineering develops cutting-edge sewage treatment tech
South Korea's Hyundai Engineering Co., an engineering solutions provider for plants, architecture, infrastructure and asset management, on Wednesday...
Sep 21, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK becomes top shareholder of US contract drug maker CBM
SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...
Sep 20, 2023 (Gmt+09:00)
-
Batteries
Battery cell prices plummet amid supply glut in China, weak EV demand
The competition among automakers to cut prices of electric vehicles is expected to intensify with battery cell prices falling at a fast pace due to ...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST discovers diabetes treatment using light
The Korea Advanced Institute of Science and Technology (KAIST) announced on Wednesday that they have discovered a method to treat diabetes by insert...
Sep 13, 2023 (Gmt+09:00)
-
Infrastructure
Shinhan, 3i, DWS to sell Dutch waste treatment firm to Ardian
South Korea’s Shinhan Asset Management Co., London-based 3i Group plc and Germany's DWS Group are set to sell their combined full stake in Dut...
Sep 13, 2023 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote the Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs